Retension Pharmaceuticals, Inc. (RTSN)

Retension Pharmaceuticals will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Retension Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Equivalents	13.49	18.9	8.19
Cash & Cash Equivalents	13.49	18.9	8.19
Cash Growth	-	130.91%	-
Other Current Assets	2.63	2.54	0.18
Total Current Assets	16.13	21.45	8.37
Total Assets	-	21.45	8.37

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Accounts Payable	-	0.78	0.19
Current Debt	-	-	0.01
Other Current Liabilities	2.88	0.14	0.08
Total Current Liabilities	2.88	0.91	0.28
Total Liabilities	-	0.91	0.28

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Retained Earnings	-	-8.32	-2.01
Shareholders' Equity	-14.92	-7.78	-1.73

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Total Debt	-	0	0.01
Debt Growth	-	-	-
Net Cash (Debt)	13.49	18.9	8.18
Net Cash (Debt) Growth	-	131.11%	-
Working Capital	13.25	20.53	8.09